Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Hamdard Medicus. 2005; 48 (2): 86-95
Dans Anglais | IMEMR | ID: emr-172016

Résumé

Pharmacogenomics is the study of how an individual's genetic inheritance affects the body's response to drugs. Pharmacogenomic studies will produce benefits for both clinical research and standard practice. The larger potential advantages include the discovery of better drugs, elimination of poor candidate drugs early in the development process, and dramatic decreases in the size and expense of clinical trials. In pharmacogenomics instead of advising patients about potential side effects, pharmacists will determine what drugs are ideal for that patient, based on their genetic information. Pharmacist's historical role in drug advice and selection would make pharmacogenetic screening fit into the pharmacist's scope of practice

SÉLECTION CITATIONS
Détails de la recherche